
Acura Pharmaceuticals ( ($ACUR) ) has released a notification of late filing. Company and Filing Details: Acura Pharmaceuticals, Inc. filed Form 12b-25 to notify investors that its Form 10-Q (Quarter
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| ACUR | Acura Pharmaceuticals | 0.00 | 0.00 | 0.00% |
| Name | Price | % Change | |
|---|---|---|---|
| $0.00 | 0.00% |

Acura Pharmaceuticals ( ($ACUR) ) has released a notification of late filing. Company and Filing Details: Acura Pharmaceuticals, Inc. filed Form 12b-25 to notify investors that its Form 10-Q (Quarter

Acura Pharmaceuticals ( ($ACUR) ) has provided an update. Acura Pharmaceuticals received loans of $41,607 on October 19, 2026, and $100,000 on October 30, 2026, from Abuse Deterrent Pharma, bringing

Acura Pharmaceuticals ( ($ACUR) ) has provided an announcement. On September 18 and October 2, 2026, Acura Pharmaceuticals received two $100,000 loans from Abuse Deterrent Pharma, LLC, bringing the principal

Acura Pharmaceuticals ( ($ACUR) ) has released a notification of late filing. Acura Pharmaceuticals, Inc. has filed a Form 12b-25 to notify investors that it will delay its Quarterly Report

Acura Pharmaceuticals ( ($ACUR) ) has issued an announcement. On August 14, 2026, Acura Pharmaceuticals received a $200,000 loan from Abuse Deterrent Pharma, LLC, increasing the principal under its amended

Acura Pharmaceuticals ( ($ACUR) ) has provided an update. On July 17, 2026, Acura Pharmaceuticals received a $200,000 loan from Abuse Deterrent Pharma, lifting the principal outstanding under a November

Acura Pharmaceuticals ( ($ACUR) ) has issued an update. On June 15, 2026, Acura Pharmaceuticals amended its secured promissory note with Abuse Deterrent Pharma, LLC, extending the note’s maturity from

Acura Pharmaceuticals ( ($ACUR) ) has released a notification of late filing. Acura Pharmaceuticals, Inc. has filed a Form 12b-25, disclosing a delay in submitting its Form 10-Q (Quarter Report)

An update from Acura Pharmaceuticals ( ($ACUR) ) is now available. Acura Pharmaceuticals disclosed that between March 30 and May 5, 2026 it received four additional $100,000 loans from major

Acura Pharmaceuticals ( ($ACUR) ) has released a notification of late filing. Acura Pharmaceuticals, Inc. has filed a Form 12b-25 to notify investors of a delay in filing its Form
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.